The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Peripheral Angioplasty and Stenting Market Research Report 2025
Synopsis
Angioplasty is a procedure that uses a catheter and a balloon to open up blocked arteries. Stenting happens after angioplasty during which your surgeon inserts a small metal device in the artery. The stent helps keep the artery open and improve blood flow.
The global Peripheral Angioplasty and Stenting market was valued at US$ 4512 million in 2023 and is anticipated to reach US$ 7056.6 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
The Peripheral Angioplasty and Stenting market is driven by the increasing prevalence of peripheral arterial disease (PAD) and the need for effective minimally invasive treatment options. Angioplasty and stenting procedures are performed to restore blood flow in narrowed or blocked peripheral arteries. The rise in PAD cases and the demand for procedures that alleviate symptoms and improve quality of life contribute to market growth as patients seek less invasive alternatives to surgical interventions. Moreover, advancements in stent technology, including improved flexibility and drug-eluting options, align with better procedural outcomes. However, the market also faces challenges, including addressing vessel tortuosity and calcification that can complicate the procedure, and the need for long-term durability of stents. Additionally, gaining reimbursement approval and promoting awareness about PAD treatment benefits can pose obstacles for manufacturers. To succeed, companies must focus on technological innovation, collaborate with vascular specialists for procedural insights, and address the challenges to meet the increasing demand for effective and patient-centric peripheral angioplasty and stenting solutions.
This report aims to provide a comprehensive presentation of the global market for Peripheral Angioplasty and Stenting, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Angioplasty and Stenting.
Report Scope
The Peripheral Angioplasty and Stenting market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peripheral Angioplasty and Stenting market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Angioplasty and Stenting manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Medtronic
Boston Scientific
BD
Yinyi
Philips
Eurocor
Aachen Resonance
Biotronic
Segment by Type
Balloon
Stent
Segment by Application
Hospitals
ASCs
Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peripheral Angioplasty and Stenting manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peripheral Angioplasty and Stenting in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Angioplasty is a procedure that uses a catheter and a balloon to open up blocked arteries. Stenting happens after angioplasty during which your surgeon inserts a small metal device in the artery. The stent helps keep the artery open and improve blood flow.
The global Peripheral Angioplasty and Stenting market was valued at US$ 4512 million in 2023 and is anticipated to reach US$ 7056.6 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
The Peripheral Angioplasty and Stenting market is driven by the increasing prevalence of peripheral arterial disease (PAD) and the need for effective minimally invasive treatment options. Angioplasty and stenting procedures are performed to restore blood flow in narrowed or blocked peripheral arteries. The rise in PAD cases and the demand for procedures that alleviate symptoms and improve quality of life contribute to market growth as patients seek less invasive alternatives to surgical interventions. Moreover, advancements in stent technology, including improved flexibility and drug-eluting options, align with better procedural outcomes. However, the market also faces challenges, including addressing vessel tortuosity and calcification that can complicate the procedure, and the need for long-term durability of stents. Additionally, gaining reimbursement approval and promoting awareness about PAD treatment benefits can pose obstacles for manufacturers. To succeed, companies must focus on technological innovation, collaborate with vascular specialists for procedural insights, and address the challenges to meet the increasing demand for effective and patient-centric peripheral angioplasty and stenting solutions.
This report aims to provide a comprehensive presentation of the global market for Peripheral Angioplasty and Stenting, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Angioplasty and Stenting.
Report Scope
The Peripheral Angioplasty and Stenting market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peripheral Angioplasty and Stenting market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Angioplasty and Stenting manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Medtronic
Boston Scientific
BD
Yinyi
Philips
Eurocor
Aachen Resonance
Biotronic
Segment by Type
Balloon
Stent
Segment by Application
Hospitals
ASCs
Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peripheral Angioplasty and Stenting manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peripheral Angioplasty and Stenting in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Peripheral Angioplasty and Stenting Market Overview
1.1 Product Overview and Scope of Peripheral Angioplasty and Stenting
1.2 Peripheral Angioplasty and Stenting Segment by Type
1.2.1 Global Peripheral Angioplasty and Stenting Market Value Comparison by Type (2024-2030)
1.2.2 Balloon
1.2.3 Stent
1.3 Peripheral Angioplasty and Stenting Segment by Application
1.3.1 Global Peripheral Angioplasty and Stenting Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 ASCs
1.3.4 Catheterization Laboratory
1.4 Global Peripheral Angioplasty and Stenting Market Size Estimates and Forecasts
1.4.1 Global Peripheral Angioplasty and Stenting Revenue 2019-2030
1.4.2 Global Peripheral Angioplasty and Stenting Sales 2019-2030
1.4.3 Global Peripheral Angioplasty and Stenting Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Peripheral Angioplasty and Stenting Market Competition by Manufacturers
2.1 Global Peripheral Angioplasty and Stenting Sales Market Share by Manufacturers (2019-2024)
2.2 Global Peripheral Angioplasty and Stenting Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Peripheral Angioplasty and Stenting Average Price by Manufacturers (2019-2024)
2.4 Global Peripheral Angioplasty and Stenting Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peripheral Angioplasty and Stenting, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peripheral Angioplasty and Stenting, Product Type & Application
2.7 Peripheral Angioplasty and Stenting Market Competitive Situation and Trends
2.7.1 Peripheral Angioplasty and Stenting Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peripheral Angioplasty and Stenting Players Market Share by Revenue
2.7.3 Global Peripheral Angioplasty and Stenting Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peripheral Angioplasty and Stenting Retrospective Market Scenario by Region
3.1 Global Peripheral Angioplasty and Stenting Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Peripheral Angioplasty and Stenting Global Peripheral Angioplasty and Stenting Sales by Region: 2019-2030
3.2.1 Global Peripheral Angioplasty and Stenting Sales by Region: 2019-2024
3.2.2 Global Peripheral Angioplasty and Stenting Sales by Region: 2025-2030
3.3 Global Peripheral Angioplasty and Stenting Global Peripheral Angioplasty and Stenting Revenue by Region: 2019-2030
3.3.1 Global Peripheral Angioplasty and Stenting Revenue by Region: 2019-2024
3.3.2 Global Peripheral Angioplasty and Stenting Revenue by Region: 2025-2030
3.4 North America Peripheral Angioplasty and Stenting Market Facts & Figures by Country
3.4.1 North America Peripheral Angioplasty and Stenting Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Peripheral Angioplasty and Stenting Sales by Country (2019-2030)
3.4.3 North America Peripheral Angioplasty and Stenting Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peripheral Angioplasty and Stenting Market Facts & Figures by Country
3.5.1 Europe Peripheral Angioplasty and Stenting Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Peripheral Angioplasty and Stenting Sales by Country (2019-2030)
3.5.3 Europe Peripheral Angioplasty and Stenting Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peripheral Angioplasty and Stenting Market Facts & Figures by Country
3.6.1 Asia Pacific Peripheral Angioplasty and Stenting Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Peripheral Angioplasty and Stenting Sales by Country (2019-2030)
3.6.3 Asia Pacific Peripheral Angioplasty and Stenting Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Peripheral Angioplasty and Stenting Market Facts & Figures by Country
3.7.1 Latin America Peripheral Angioplasty and Stenting Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Peripheral Angioplasty and Stenting Sales by Country (2019-2030)
3.7.3 Latin America Peripheral Angioplasty and Stenting Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peripheral Angioplasty and Stenting Market Facts & Figures by Country
3.8.1 Middle East and Africa Peripheral Angioplasty and Stenting Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Peripheral Angioplasty and Stenting Sales by Country (2019-2030)
3.8.3 Middle East and Africa Peripheral Angioplasty and Stenting Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peripheral Angioplasty and Stenting Sales by Type (2019-2030)
4.1.1 Global Peripheral Angioplasty and Stenting Sales by Type (2019-2024)
4.1.2 Global Peripheral Angioplasty and Stenting Sales by Type (2025-2030)
4.1.3 Global Peripheral Angioplasty and Stenting Sales Market Share by Type (2019-2030)
4.2 Global Peripheral Angioplasty and Stenting Revenue by Type (2019-2030)
4.2.1 Global Peripheral Angioplasty and Stenting Revenue by Type (2019-2024)
4.2.2 Global Peripheral Angioplasty and Stenting Revenue by Type (2025-2030)
4.2.3 Global Peripheral Angioplasty and Stenting Revenue Market Share by Type (2019-2030)
4.3 Global Peripheral Angioplasty and Stenting Price by Type (2019-2030)
5 Segment by Application
5.1 Global Peripheral Angioplasty and Stenting Sales by Application (2019-2030)
5.1.1 Global Peripheral Angioplasty and Stenting Sales by Application (2019-2024)
5.1.2 Global Peripheral Angioplasty and Stenting Sales by Application (2025-2030)
5.1.3 Global Peripheral Angioplasty and Stenting Sales Market Share by Application (2019-2030)
5.2 Global Peripheral Angioplasty and Stenting Revenue by Application (2019-2030)
5.2.1 Global Peripheral Angioplasty and Stenting Revenue by Application (2019-2024)
5.2.2 Global Peripheral Angioplasty and Stenting Revenue by Application (2025-2030)
5.2.3 Global Peripheral Angioplasty and Stenting Revenue Market Share by Application (2019-2030)
5.3 Global Peripheral Angioplasty and Stenting Price by Application (2019-2030)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Corporation Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2019-2024)
6.1.4 B. Braun Peripheral Angioplasty and Stenting Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Peripheral Angioplasty and Stenting Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boston Scientific Peripheral Angioplasty and Stenting Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BD Peripheral Angioplasty and Stenting Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Yinyi
6.5.1 Yinyi Corporation Information
6.5.2 Yinyi Description and Business Overview
6.5.3 Yinyi Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Yinyi Peripheral Angioplasty and Stenting Product Portfolio
6.5.5 Yinyi Recent Developments/Updates
6.6 Philips
6.6.1 Philips Corporation Information
6.6.2 Philips Description and Business Overview
6.6.3 Philips Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Philips Peripheral Angioplasty and Stenting Product Portfolio
6.6.5 Philips Recent Developments/Updates
6.7 Eurocor
6.6.1 Eurocor Corporation Information
6.6.2 Eurocor Description and Business Overview
6.6.3 Eurocor Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eurocor Peripheral Angioplasty and Stenting Product Portfolio
6.7.5 Eurocor Recent Developments/Updates
6.8 Aachen Resonance
6.8.1 Aachen Resonance Corporation Information
6.8.2 Aachen Resonance Description and Business Overview
6.8.3 Aachen Resonance Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aachen Resonance Peripheral Angioplasty and Stenting Product Portfolio
6.8.5 Aachen Resonance Recent Developments/Updates
6.9 Biotronic
6.9.1 Biotronic Corporation Information
6.9.2 Biotronic Description and Business Overview
6.9.3 Biotronic Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biotronic Peripheral Angioplasty and Stenting Product Portfolio
6.9.5 Biotronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peripheral Angioplasty and Stenting Industry Chain Analysis
7.2 Peripheral Angioplasty and Stenting Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peripheral Angioplasty and Stenting Production Mode & Process
7.4 Peripheral Angioplasty and Stenting Sales and Marketing
7.4.1 Peripheral Angioplasty and Stenting Sales Channels
7.4.2 Peripheral Angioplasty and Stenting Distributors
7.5 Peripheral Angioplasty and Stenting Customers
8 Peripheral Angioplasty and Stenting Market Dynamics
8.1 Peripheral Angioplasty and Stenting Industry Trends
8.2 Peripheral Angioplasty and Stenting Market Drivers
8.3 Peripheral Angioplasty and Stenting Market Challenges
8.4 Peripheral Angioplasty and Stenting Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Peripheral Angioplasty and Stenting Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Peripheral Angioplasty and Stenting Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Peripheral Angioplasty and Stenting Market Competitive Situation by Manufacturers in 2023
Table 4. Global Peripheral Angioplasty and Stenting Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Peripheral Angioplasty and Stenting Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Peripheral Angioplasty and Stenting Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Peripheral Angioplasty and Stenting Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Peripheral Angioplasty and Stenting Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Peripheral Angioplasty and Stenting, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peripheral Angioplasty and Stenting, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peripheral Angioplasty and Stenting, Product Type & Application
Table 12. Global Key Manufacturers of Peripheral Angioplasty and Stenting, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peripheral Angioplasty and Stenting by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Angioplasty and Stenting as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peripheral Angioplasty and Stenting Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Peripheral Angioplasty and Stenting Sales by Region (2019-2024) & (K Units)
Table 18. Global Peripheral Angioplasty and Stenting Sales Market Share by Region (2019-2024)
Table 19. Global Peripheral Angioplasty and Stenting Sales by Region (2025-2030) & (K Units)
Table 20. Global Peripheral Angioplasty and Stenting Sales Market Share by Region (2025-2030)
Table 21. Global Peripheral Angioplasty and Stenting Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Peripheral Angioplasty and Stenting Revenue Market Share by Region (2019-2024)
Table 23. Global Peripheral Angioplasty and Stenting Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Peripheral Angioplasty and Stenting Revenue Market Share by Region (2025-2030)
Table 25. North America Peripheral Angioplasty and Stenting Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Peripheral Angioplasty and Stenting Sales by Country (2019-2024) & (K Units)
Table 27. North America Peripheral Angioplasty and Stenting Sales by Country (2025-2030) & (K Units)
Table 28. North America Peripheral Angioplasty and Stenting Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Peripheral Angioplasty and Stenting Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Peripheral Angioplasty and Stenting Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Peripheral Angioplasty and Stenting Sales by Country (2019-2024) & (K Units)
Table 32. Europe Peripheral Angioplasty and Stenting Sales by Country (2025-2030) & (K Units)
Table 33. Europe Peripheral Angioplasty and Stenting Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Peripheral Angioplasty and Stenting Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Peripheral Angioplasty and Stenting Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Peripheral Angioplasty and Stenting Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Peripheral Angioplasty and Stenting Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Peripheral Angioplasty and Stenting Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Peripheral Angioplasty and Stenting Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Peripheral Angioplasty and Stenting Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Peripheral Angioplasty and Stenting Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Peripheral Angioplasty and Stenting Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Peripheral Angioplasty and Stenting Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Peripheral Angioplasty and Stenting Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Peripheral Angioplasty and Stenting Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Peripheral Angioplasty and Stenting Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Peripheral Angioplasty and Stenting Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Peripheral Angioplasty and Stenting Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Peripheral Angioplasty and Stenting Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Peripheral Angioplasty and Stenting Sales (K Units) by Type (2019-2024)
Table 51. Global Peripheral Angioplasty and Stenting Sales (K Units) by Type (2025-2030)
Table 52. Global Peripheral Angioplasty and Stenting Sales Market Share by Type (2019-2024)
Table 53. Global Peripheral Angioplasty and Stenting Sales Market Share by Type (2025-2030)
Table 54. Global Peripheral Angioplasty and Stenting Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Peripheral Angioplasty and Stenting Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Peripheral Angioplasty and Stenting Revenue Market Share by Type (2019-2024)
Table 57. Global Peripheral Angioplasty and Stenting Revenue Market Share by Type (2025-2030)
Table 58. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Type (2019-2024)
Table 59. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Type (2025-2030)
Table 60. Global Peripheral Angioplasty and Stenting Sales (K Units) by Application (2019-2024)
Table 61. Global Peripheral Angioplasty and Stenting Sales (K Units) by Application (2025-2030)
Table 62. Global Peripheral Angioplasty and Stenting Sales Market Share by Application (2019-2024)
Table 63. Global Peripheral Angioplasty and Stenting Sales Market Share by Application (2025-2030)
Table 64. Global Peripheral Angioplasty and Stenting Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Peripheral Angioplasty and Stenting Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Peripheral Angioplasty and Stenting Revenue Market Share by Application (2019-2024)
Table 67. Global Peripheral Angioplasty and Stenting Revenue Market Share by Application (2025-2030)
Table 68. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Application (2019-2024)
Table 69. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Application (2025-2030)
Table 70. B. Braun Corporation Information
Table 71. B. Braun Description and Business Overview
Table 72. B. Braun Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. B. Braun Peripheral Angioplasty and Stenting Product
Table 74. B. Braun Recent Developments/Updates
Table 75. Medtronic Corporation Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Medtronic Peripheral Angioplasty and Stenting Product
Table 79. Medtronic Recent Developments/Updates
Table 80. Boston Scientific Corporation Information
Table 81. Boston Scientific Description and Business Overview
Table 82. Boston Scientific Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boston Scientific Peripheral Angioplasty and Stenting Product
Table 84. Boston Scientific Recent Developments/Updates
Table 85. BD Corporation Information
Table 86. BD Description and Business Overview
Table 87. BD Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. BD Peripheral Angioplasty and Stenting Product
Table 89. BD Recent Developments/Updates
Table 90. Yinyi Corporation Information
Table 91. Yinyi Description and Business Overview
Table 92. Yinyi Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Yinyi Peripheral Angioplasty and Stenting Product
Table 94. Yinyi Recent Developments/Updates
Table 95. Philips Corporation Information
Table 96. Philips Description and Business Overview
Table 97. Philips Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Philips Peripheral Angioplasty and Stenting Product
Table 99. Philips Recent Developments/Updates
Table 100. Eurocor Corporation Information
Table 101. Eurocor Description and Business Overview
Table 102. Eurocor Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Eurocor Peripheral Angioplasty and Stenting Product
Table 104. Eurocor Recent Developments/Updates
Table 105. Aachen Resonance Corporation Information
Table 106. Aachen Resonance Description and Business Overview
Table 107. Aachen Resonance Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Aachen Resonance Peripheral Angioplasty and Stenting Product
Table 109. Aachen Resonance Recent Developments/Updates
Table 110. Biotronic Corporation Information
Table 111. Biotronic Description and Business Overview
Table 112. Biotronic Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Biotronic Peripheral Angioplasty and Stenting Product
Table 114. Biotronic Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Peripheral Angioplasty and Stenting Distributors List
Table 118. Peripheral Angioplasty and Stenting Customers List
Table 119. Peripheral Angioplasty and Stenting Market Trends
Table 120. Peripheral Angioplasty and Stenting Market Drivers
Table 121. Peripheral Angioplasty and Stenting Market Challenges
Table 122. Peripheral Angioplasty and Stenting Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Peripheral Angioplasty and Stenting
Figure 2. Global Peripheral Angioplasty and Stenting Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Peripheral Angioplasty and Stenting Market Share by Type in 2023 & 2030
Figure 4. Balloon Product Picture
Figure 5. Stent Product Picture
Figure 6. Global Peripheral Angioplasty and Stenting Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Peripheral Angioplasty and Stenting Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. ASCs
Figure 10. Catheterization Laboratory
Figure 11. Global Peripheral Angioplasty and Stenting Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Peripheral Angioplasty and Stenting Market Size (2019-2030) & (US$ Million)
Figure 13. Global Peripheral Angioplasty and Stenting Sales (2019-2030) & (K Units)
Figure 14. Global Peripheral Angioplasty and Stenting Average Price (US$/Unit) & (2019-2030)
Figure 15. Peripheral Angioplasty and Stenting Report Years Considered
Figure 16. Peripheral Angioplasty and Stenting Sales Share by Manufacturers in 2023
Figure 17. Global Peripheral Angioplasty and Stenting Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Peripheral Angioplasty and Stenting Players: Market Share by Revenue in 2023
Figure 19. Peripheral Angioplasty and Stenting Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Peripheral Angioplasty and Stenting Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Peripheral Angioplasty and Stenting Sales Market Share by Country (2019-2030)
Figure 22. North America Peripheral Angioplasty and Stenting Revenue Market Share by Country (2019-2030)
Figure 23. United States Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Peripheral Angioplasty and Stenting Sales Market Share by Country (2019-2030)
Figure 26. Europe Peripheral Angioplasty and Stenting Revenue Market Share by Country (2019-2030)
Figure 27. Germany Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Peripheral Angioplasty and Stenting Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Peripheral Angioplasty and Stenting Revenue Market Share by Region (2019-2030)
Figure 34. China Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Peripheral Angioplasty and Stenting Sales Market Share by Country (2019-2030)
Figure 44. Latin America Peripheral Angioplasty and Stenting Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Peripheral Angioplasty and Stenting Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Peripheral Angioplasty and Stenting Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Peripheral Angioplasty and Stenting Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Peripheral Angioplasty and Stenting by Type (2019-2030)
Figure 54. Global Revenue Market Share of Peripheral Angioplasty and Stenting by Type (2019-2030)
Figure 55. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Peripheral Angioplasty and Stenting by Application (2019-2030)
Figure 57. Global Revenue Market Share of Peripheral Angioplasty and Stenting by Application (2019-2030)
Figure 58. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Application (2019-2030)
Figure 59. Peripheral Angioplasty and Stenting Value Chain
Figure 60. Peripheral Angioplasty and Stenting Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
